Nabiximols is a delta-9-tetrahydrocannabinol (THC)/cannabidiol (CBD) combination for the treatment of multiple sclerosis (MS) related moderate to severe spasticity.

56575-23-6

C42H60O4

628.938

GW1000;GW 1000;GW-1000;SAB-378;SAB 378;SAB378;Nabiximols

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years